Clinical Trial Update: Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and efficacy of pembrolizumab in combination with chemotherapy for newly diagnosed classical Hodgkin lymphoma has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Classical Hodgkin Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2024-10-16